innovative gene delivery solutions

Gene delivery to the outer retina, i.e. the photoreceptors can generally only be achieved via the subretinal route of injection, i.e. a surgical procedure.

Millions of people receive intravitreal injection of drugs as an office procedure every 6 to 8 weeks and such injections are considered safe.

We have developed an adeno-associated virus that can deliver genes to the outer retina via an intravitreal injection.

Development of this technology has the potential for wide scale application of retinal gene therapy as an office procedure.